Study of m-RESIST, an m-Health Program for Treatment-resistant Schizophrenia

NACompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

July 1, 2017

Study Completion Date

June 1, 2019

Conditions
Schizophrenia
Interventions
DEVICE

m-RESIST Patients

A mobile system based on Information and Communications Technology (ICT), which is addressed to empower patients suffering from TRS and to involve their caregivers

DEVICE

m-RESIST Caregivers

A mobile system based on Information and Communications Technology (ICT), which is addressed to empower patients suffering from TRS and to involve their caregivers

Trial Locations (3)

Unknown

3Department of Psychiatry and Psychotherapy, Semmelweis University, Budapest

The Gertner Institute of Epidemiology and Health Policy Research, Sheba Medical Center, Tel Aviv

08025

Department of Psychiatry. Hospital Santa Creu i Sant Pau, Barcelona

All Listed Sponsors
collaborator

Sheba Medical Center

OTHER_GOV

collaborator

Semmelweis University

OTHER

collaborator

iMinds

INDUSTRY

collaborator

AQuAS, Agència de Qualitat i Avaluació Sanitàries

UNKNOWN

lead

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

OTHER

NCT03064776 - Study of m-RESIST, an m-Health Program for Treatment-resistant Schizophrenia | Biotech Hunter | Biotech Hunter